We are delighted to announce that Naoka Murakami, MD, PhD, has joined WashU Nephrology as an Assistant Professor, effective September 1, 2024. She comes to us from the Division of Nephrology at Brigham and Women’s Hospital and Harvard Medical School.
Dr. Murakami earned her MD and PhD from Tokyo University and completed her residency training at Toranomon Hospital in Tokyo. She furthered her internal medicine residency at Mt. Sinai Beth Israel in New York, followed by nephrology and transplant nephrology training at Brigham and Women’s Hospital and Massachusetts General Hospital. In 2019, she joined the faculty of Harvard Medical School in the Division of Nephrology at Brigham and Women’s Hospital.
As a physician-scientist and transplant nephrologist, Dr. Murakami’s lab focuses on the roles of co-stimulatory signaling in autoimmune disease and kidney transplant rejection and tolerance. She also has extensive expertise in onco-nephrology. She led an international multi-center trial to study the outcomes of kidney transplant recipients treated with immune checkpoint blockade and is a founding member of the American Society of Onconephrology. Additionally, she conducts basic research into the mechanisms of kidney allograft rejection associated with checkpoint blockade.
Dr. Murakami holds a recently funded NIH R01 award and has previously received the Carl Gottschalk Research Scholar Award (2019), an NIH K08 award, and foundation support. She has been honored with the Young Investigator Award from the American Society of Transplantation and the ISN-Kidney International (KI) Early Career Researcher Award-Clinical Science from the International Society of Nephrology.
Follow @nymurakami on X.
Keep Up with the Latest WashU Nephrology News
Please visit our website and the following social media sites, especially our new Instagram account @WashUNeph (#WashuNeph, #nephStrong):
